ACS Global, Inc.
ACS Global, Inc. AMCY Peers
See (AMCY) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| AMCY | $3.00 | -40.00% | 171.3M | N/A | N/A | N/A |
| LZAGY | $69.60 | +2.08% | 50.2B | 63.85 | $1.09 | +0.74% |
| LZAGF | $705.26 | +2.90% | 49.6B | 65.97 | $10.69 | +0.41% |
| WUXAY | $8.73 | -1.58% | 25B | 16.17 | $0.54 | +0.72% |
| WUXIF | $7.34 | N/A | 20.7B | 13.59 | $0.54 | +2.54% |
| BMXMF | $136.00 | +1.30% | 16B | 32.93 | $4.13 | +0.68% |
| ERFSF | $67.36 | +0.01% | 11.9B | 28.30 | $2.38 | +1.57% |
| SKHCF | $18.08 | +10.31% | 8.7B | 24.77 | $0.73 | +3.88% |
| SKHHY | $17.28 | -0.46% | 8.3B | 23.67 | $0.73 | +3.91% |
| DSRLF | $104.69 | N/A | 5.6B | 26.57 | $3.94 | +1.31% |
Stock Comparison
AMCY vs LZAGY Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, LZAGY has a market cap of 50.2B. Regarding current trading prices, AMCY is priced at $3.00, while LZAGY trades at $69.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas LZAGY's P/E ratio is 63.85. In terms of profitability, AMCY's ROE is N/A, compared to LZAGY's ROE of +0.06%. Regarding short-term risk, AMCY is less volatile compared to LZAGY. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs LZAGF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, LZAGF has a market cap of 49.6B. Regarding current trading prices, AMCY is priced at $3.00, while LZAGF trades at $705.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas LZAGF's P/E ratio is 65.97. In terms of profitability, AMCY's ROE is N/A, compared to LZAGF's ROE of +0.06%. Regarding short-term risk, AMCY is less volatile compared to LZAGF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs WUXAY Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, WUXAY has a market cap of 25B. Regarding current trading prices, AMCY is priced at $3.00, while WUXAY trades at $8.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas WUXAY's P/E ratio is 16.17. In terms of profitability, AMCY's ROE is N/A, compared to WUXAY's ROE of +0.19%. Regarding short-term risk, AMCY is less volatile compared to WUXAY. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs WUXIF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, WUXIF has a market cap of 20.7B. Regarding current trading prices, AMCY is priced at $3.00, while WUXIF trades at $7.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas WUXIF's P/E ratio is 13.59. In terms of profitability, AMCY's ROE is N/A, compared to WUXIF's ROE of +0.19%. Regarding short-term risk, AMCY and WUXIF have similar daily volatility (0.00).
AMCY vs BMXMF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, BMXMF has a market cap of 16B. Regarding current trading prices, AMCY is priced at $3.00, while BMXMF trades at $136.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas BMXMF's P/E ratio is 32.93. In terms of profitability, AMCY's ROE is N/A, compared to BMXMF's ROE of +0.10%. Regarding short-term risk, AMCY and BMXMF have similar daily volatility (0.00).
AMCY vs ERFSF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, ERFSF has a market cap of 11.9B. Regarding current trading prices, AMCY is priced at $3.00, while ERFSF trades at $67.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas ERFSF's P/E ratio is 28.30. In terms of profitability, AMCY's ROE is N/A, compared to ERFSF's ROE of +0.07%. Regarding short-term risk, AMCY is less volatile compared to ERFSF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs SKHCF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, SKHCF has a market cap of 8.7B. Regarding current trading prices, AMCY is priced at $3.00, while SKHCF trades at $18.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas SKHCF's P/E ratio is 24.77. In terms of profitability, AMCY's ROE is N/A, compared to SKHCF's ROE of +0.05%. Regarding short-term risk, AMCY and SKHCF have similar daily volatility (0.00).
AMCY vs SKHHY Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, SKHHY has a market cap of 8.3B. Regarding current trading prices, AMCY is priced at $3.00, while SKHHY trades at $17.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas SKHHY's P/E ratio is 23.67. In terms of profitability, AMCY's ROE is N/A, compared to SKHHY's ROE of +0.07%. Regarding short-term risk, AMCY is less volatile compared to SKHHY. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs DSRLF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, DSRLF has a market cap of 5.6B. Regarding current trading prices, AMCY is priced at $3.00, while DSRLF trades at $104.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas DSRLF's P/E ratio is 26.57. In terms of profitability, AMCY's ROE is N/A, compared to DSRLF's ROE of +0.09%. Regarding short-term risk, AMCY is less volatile compared to DSRLF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs HNGZY Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, HNGZY has a market cap of 5.1B. Regarding current trading prices, AMCY is priced at $3.00, while HNGZY trades at $4.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas HNGZY's P/E ratio is 26.67. In terms of profitability, AMCY's ROE is N/A, compared to HNGZY's ROE of +0.02%. Regarding short-term risk, AMCY is less volatile compared to HNGZY. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs VIMGF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, VIMGF has a market cap of 1.8B. Regarding current trading prices, AMCY is priced at $3.00, while VIMGF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas VIMGF's P/E ratio is 70.00. In terms of profitability, AMCY's ROE is N/A, compared to VIMGF's ROE of +0.03%. Regarding short-term risk, AMCY and VIMGF have similar daily volatility (0.00).
AMCY vs MRCHF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, MRCHF has a market cap of 1.2B. Regarding current trading prices, AMCY is priced at $3.00, while MRCHF trades at $21.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas MRCHF's P/E ratio is 61.83. In terms of profitability, AMCY's ROE is N/A, compared to MRCHF's ROE of -0.04%. Regarding short-term risk, AMCY is less volatile compared to MRCHF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs IDGXF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, IDGXF has a market cap of 186M. Regarding current trading prices, AMCY is priced at $3.00, while IDGXF trades at $0.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas IDGXF's P/E ratio is 8.00. In terms of profitability, AMCY's ROE is N/A, compared to IDGXF's ROE of +0.24%. Regarding short-term risk, AMCY is less volatile compared to IDGXF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs EDTXF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, EDTXF has a market cap of 172.6M. Regarding current trading prices, AMCY is priced at $3.00, while EDTXF trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas EDTXF's P/E ratio is -10.09. In terms of profitability, AMCY's ROE is N/A, compared to EDTXF's ROE of +0.79%. Regarding short-term risk, AMCY and EDTXF have similar daily volatility (0.00).
AMCY vs NNGRF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, NNGRF has a market cap of 164.3M. Regarding current trading prices, AMCY is priced at $3.00, while NNGRF trades at $12.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas NNGRF's P/E ratio is 60.75. In terms of profitability, AMCY's ROE is N/A, compared to NNGRF's ROE of -0.07%. Regarding short-term risk, AMCY and NNGRF have similar daily volatility (0.00).
AMCY vs CORBF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, CORBF has a market cap of 158.7M. Regarding current trading prices, AMCY is priced at $3.00, while CORBF trades at $1.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas CORBF's P/E ratio is 3.59. In terms of profitability, AMCY's ROE is N/A, compared to CORBF's ROE of +0.11%. Regarding short-term risk, AMCY is less volatile compared to CORBF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs THOXF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, THOXF has a market cap of 130.9M. Regarding current trading prices, AMCY is priced at $3.00, while THOXF trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas THOXF's P/E ratio is -14.40. In terms of profitability, AMCY's ROE is N/A, compared to THOXF's ROE of -0.91%. Regarding short-term risk, AMCY is less volatile compared to THOXF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs DIUXF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, DIUXF has a market cap of 115.5M. Regarding current trading prices, AMCY is priced at $3.00, while DIUXF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas DIUXF's P/E ratio is 136.72. In terms of profitability, AMCY's ROE is N/A, compared to DIUXF's ROE of -0.07%. Regarding short-term risk, AMCY and DIUXF have similar daily volatility (0.00).
AMCY vs ANPCF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, ANPCF has a market cap of 100M. Regarding current trading prices, AMCY is priced at $3.00, while ANPCF trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas ANPCF's P/E ratio is -3.10. In terms of profitability, AMCY's ROE is N/A, compared to ANPCF's ROE of -0.54%. Regarding short-term risk, AMCY is less volatile compared to ANPCF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs TIHE Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, TIHE has a market cap of 71.9M. Regarding current trading prices, AMCY is priced at $3.00, while TIHE trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas TIHE's P/E ratio is 0.32. In terms of profitability, AMCY's ROE is N/A, compared to TIHE's ROE of +0.01%. Regarding short-term risk, AMCY and TIHE have similar daily volatility (0.00).
AMCY vs BIOGF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, BIOGF has a market cap of 65.4M. Regarding current trading prices, AMCY is priced at $3.00, while BIOGF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas BIOGF's P/E ratio is -0.67. In terms of profitability, AMCY's ROE is N/A, compared to BIOGF's ROE of +2.04%. Regarding short-term risk, AMCY and BIOGF have similar daily volatility (0.00).
AMCY vs PCNEF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, PCNEF has a market cap of 62M. Regarding current trading prices, AMCY is priced at $3.00, while PCNEF trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas PCNEF's P/E ratio is -8.44. In terms of profitability, AMCY's ROE is N/A, compared to PCNEF's ROE of -0.21%. Regarding short-term risk, AMCY and PCNEF have similar daily volatility (0.00).
AMCY vs PFGTF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, PFGTF has a market cap of 50.6M. Regarding current trading prices, AMCY is priced at $3.00, while PFGTF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas PFGTF's P/E ratio is -3.11. In terms of profitability, AMCY's ROE is N/A, compared to PFGTF's ROE of -0.41%. Regarding short-term risk, AMCY and PFGTF have similar daily volatility (0.00).
AMCY vs CLIFF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, CLIFF has a market cap of 44.1M. Regarding current trading prices, AMCY is priced at $3.00, while CLIFF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas CLIFF's P/E ratio is -2.87. In terms of profitability, AMCY's ROE is N/A, compared to CLIFF's ROE of -0.08%. Regarding short-term risk, AMCY is less volatile compared to CLIFF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs BIOQ Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, BIOQ has a market cap of 39.6M. Regarding current trading prices, AMCY is priced at $3.00, while BIOQ trades at $44.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas BIOQ's P/E ratio is 15.58. In terms of profitability, AMCY's ROE is N/A, compared to BIOQ's ROE of -0.06%. Regarding short-term risk, AMCY is less volatile compared to BIOQ. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs ANPCY Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, ANPCY has a market cap of 31.2M. Regarding current trading prices, AMCY is priced at $3.00, while ANPCY trades at $0.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas ANPCY's P/E ratio is -1.49. In terms of profitability, AMCY's ROE is N/A, compared to ANPCY's ROE of -0.75%. Regarding short-term risk, AMCY is less volatile compared to ANPCY. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs SNANF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, SNANF has a market cap of 30.3M. Regarding current trading prices, AMCY is priced at $3.00, while SNANF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas SNANF's P/E ratio is -14.00. In terms of profitability, AMCY's ROE is N/A, compared to SNANF's ROE of -2.51%. Regarding short-term risk, AMCY is less volatile compared to SNANF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs IMMVF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, IMMVF has a market cap of 22.6M. Regarding current trading prices, AMCY is priced at $3.00, while IMMVF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas IMMVF's P/E ratio is -0.32. In terms of profitability, AMCY's ROE is N/A, compared to IMMVF's ROE of -2.69%. Regarding short-term risk, AMCY is less volatile compared to IMMVF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs PCHM Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, PCHM has a market cap of 21.9M. Regarding current trading prices, AMCY is priced at $3.00, while PCHM trades at $3.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas PCHM's P/E ratio is -0.02. In terms of profitability, AMCY's ROE is N/A, compared to PCHM's ROE of +0.53%. Regarding short-term risk, AMCY is less volatile compared to PCHM. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs BMKDF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, BMKDF has a market cap of 21.1M. Regarding current trading prices, AMCY is priced at $3.00, while BMKDF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas BMKDF's P/E ratio is -23.17. In terms of profitability, AMCY's ROE is N/A, compared to BMKDF's ROE of +2.24%. Regarding short-term risk, AMCY is less volatile compared to BMKDF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs VILGF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, VILGF has a market cap of 20.7M. Regarding current trading prices, AMCY is priced at $3.00, while VILGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas VILGF's P/E ratio is -0.30. In terms of profitability, AMCY's ROE is N/A, compared to VILGF's ROE of N/A. Regarding short-term risk, AMCY and VILGF have similar daily volatility (0.00).
AMCY vs LDXHF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, LDXHF has a market cap of 19.5M. Regarding current trading prices, AMCY is priced at $3.00, while LDXHF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas LDXHF's P/E ratio is -2.60. In terms of profitability, AMCY's ROE is N/A, compared to LDXHF's ROE of -1.38%. Regarding short-term risk, AMCY is less volatile compared to LDXHF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs PMSNF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, PMSNF has a market cap of 14.8M. Regarding current trading prices, AMCY is priced at $3.00, while PMSNF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas PMSNF's P/E ratio is -2.50. In terms of profitability, AMCY's ROE is N/A, compared to PMSNF's ROE of +0.69%. Regarding short-term risk, AMCY and PMSNF have similar daily volatility (0.00).
AMCY vs ABDXF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, ABDXF has a market cap of 13.6M. Regarding current trading prices, AMCY is priced at $3.00, while ABDXF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas ABDXF's P/E ratio is -1.40. In terms of profitability, AMCY's ROE is N/A, compared to ABDXF's ROE of -0.63%. Regarding short-term risk, AMCY and ABDXF have similar daily volatility (0.00).
AMCY vs IZOZF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, IZOZF has a market cap of 11.6M. Regarding current trading prices, AMCY is priced at $3.00, while IZOZF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas IZOZF's P/E ratio is -6.39. In terms of profitability, AMCY's ROE is N/A, compared to IZOZF's ROE of +0.47%. Regarding short-term risk, AMCY is less volatile compared to IZOZF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs MXDHF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, MXDHF has a market cap of 8.6M. Regarding current trading prices, AMCY is priced at $3.00, while MXDHF trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas MXDHF's P/E ratio is -0.12. In terms of profitability, AMCY's ROE is N/A, compared to MXDHF's ROE of -6.91%. Regarding short-term risk, AMCY and MXDHF have similar daily volatility (0.00).
AMCY vs VRCDF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, VRCDF has a market cap of 7.3M. Regarding current trading prices, AMCY is priced at $3.00, while VRCDF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas VRCDF's P/E ratio is -1.00. In terms of profitability, AMCY's ROE is N/A, compared to VRCDF's ROE of -0.73%. Regarding short-term risk, AMCY is less volatile compared to VRCDF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs SQIDF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, SQIDF has a market cap of 6.1M. Regarding current trading prices, AMCY is priced at $3.00, while SQIDF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas SQIDF's P/E ratio is -0.37. In terms of profitability, AMCY's ROE is N/A, compared to SQIDF's ROE of +4.47%. Regarding short-term risk, AMCY is less volatile compared to SQIDF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs TDSGF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, TDSGF has a market cap of 5.7M. Regarding current trading prices, AMCY is priced at $3.00, while TDSGF trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas TDSGF's P/E ratio is -1.90. In terms of profitability, AMCY's ROE is N/A, compared to TDSGF's ROE of -3.19%. Regarding short-term risk, AMCY and TDSGF have similar daily volatility (0.00).
AMCY vs SLDX Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, SLDX has a market cap of 4.8M. Regarding current trading prices, AMCY is priced at $3.00, while SLDX trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas SLDX's P/E ratio is -0.01. In terms of profitability, AMCY's ROE is N/A, compared to SLDX's ROE of +0.06%. Regarding short-term risk, AMCY is less volatile compared to SLDX. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs RNVA Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, RNVA has a market cap of 4.3M. Regarding current trading prices, AMCY is priced at $3.00, while RNVA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas RNVA's P/E ratio is N/A. In terms of profitability, AMCY's ROE is N/A, compared to RNVA's ROE of +0.23%. Regarding short-term risk, AMCY and RNVA have similar daily volatility (0.00).
AMCY vs AVCRF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, AVCRF has a market cap of 4.3M. Regarding current trading prices, AMCY is priced at $3.00, while AVCRF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas AVCRF's P/E ratio is -4.23. In terms of profitability, AMCY's ROE is N/A, compared to AVCRF's ROE of +0.05%. Regarding short-term risk, AMCY is less volatile compared to AVCRF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs JMPHF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, JMPHF has a market cap of 4.2M. Regarding current trading prices, AMCY is priced at $3.00, while JMPHF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas JMPHF's P/E ratio is -0.91. In terms of profitability, AMCY's ROE is N/A, compared to JMPHF's ROE of -0.11%. Regarding short-term risk, AMCY is less volatile compared to JMPHF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs ICBU Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, ICBU has a market cap of 3.7M. Regarding current trading prices, AMCY is priced at $3.00, while ICBU trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas ICBU's P/E ratio is N/A. In terms of profitability, AMCY's ROE is N/A, compared to ICBU's ROE of +0.70%. Regarding short-term risk, AMCY is less volatile compared to ICBU. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs GNTLF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, GNTLF has a market cap of 3.7M. Regarding current trading prices, AMCY is priced at $3.00, while GNTLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas GNTLF's P/E ratio is -16.67. In terms of profitability, AMCY's ROE is N/A, compared to GNTLF's ROE of -3.62%. Regarding short-term risk, AMCY and GNTLF have similar daily volatility (0.00).
AMCY vs SZLSF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, SZLSF has a market cap of 3.6M. Regarding current trading prices, AMCY is priced at $3.00, while SZLSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas SZLSF's P/E ratio is -0.02. In terms of profitability, AMCY's ROE is N/A, compared to SZLSF's ROE of +0.13%. Regarding short-term risk, AMCY is less volatile compared to SZLSF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs IDXG Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, IDXG has a market cap of 3.5M. Regarding current trading prices, AMCY is priced at $3.00, while IDXG trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas IDXG's P/E ratio is 2.79. In terms of profitability, AMCY's ROE is N/A, compared to IDXG's ROE of -1.19%. Regarding short-term risk, AMCY and IDXG have similar daily volatility (0.00).
AMCY vs IDTA Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, IDTA has a market cap of 1.7M. Regarding current trading prices, AMCY is priced at $3.00, while IDTA trades at $0.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas IDTA's P/E ratio is 4.15. In terms of profitability, AMCY's ROE is N/A, compared to IDTA's ROE of +0.36%. Regarding short-term risk, AMCY is less volatile compared to IDTA. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs IBXXF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, IBXXF has a market cap of 1.6M. Regarding current trading prices, AMCY is priced at $3.00, while IBXXF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas IBXXF's P/E ratio is -0.27. In terms of profitability, AMCY's ROE is N/A, compared to IBXXF's ROE of +0.55%. Regarding short-term risk, AMCY is less volatile compared to IBXXF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs IVRO Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, IVRO has a market cap of 1.6M. Regarding current trading prices, AMCY is priced at $3.00, while IVRO trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas IVRO's P/E ratio is -0.77. In terms of profitability, AMCY's ROE is N/A, compared to IVRO's ROE of +0.08%. Regarding short-term risk, AMCY is less volatile compared to IVRO. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs NSTM Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, NSTM has a market cap of 1.2M. Regarding current trading prices, AMCY is priced at $3.00, while NSTM trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas NSTM's P/E ratio is -0.44. In terms of profitability, AMCY's ROE is N/A, compared to NSTM's ROE of +0.87%. Regarding short-term risk, AMCY and NSTM have similar daily volatility (0.00).
AMCY vs DIGP Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, DIGP has a market cap of 1.1M. Regarding current trading prices, AMCY is priced at $3.00, while DIGP trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas DIGP's P/E ratio is -1.04. In terms of profitability, AMCY's ROE is N/A, compared to DIGP's ROE of +3.08%. Regarding short-term risk, AMCY is less volatile compared to DIGP. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs SCRSF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, SCRSF has a market cap of 906.3K. Regarding current trading prices, AMCY is priced at $3.00, while SCRSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas SCRSF's P/E ratio is -0.09. In terms of profitability, AMCY's ROE is N/A, compared to SCRSF's ROE of +2.91%. Regarding short-term risk, AMCY and SCRSF have similar daily volatility (0.00).
AMCY vs RSHN Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, RSHN has a market cap of 817.5K. Regarding current trading prices, AMCY is priced at $3.00, while RSHN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas RSHN's P/E ratio is N/A. In terms of profitability, AMCY's ROE is N/A, compared to RSHN's ROE of -5.42%. Regarding short-term risk, AMCY and RSHN have similar daily volatility (0.00).
AMCY vs EPGNF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, EPGNF has a market cap of 692.8K. Regarding current trading prices, AMCY is priced at $3.00, while EPGNF trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas EPGNF's P/E ratio is -0.04. In terms of profitability, AMCY's ROE is N/A, compared to EPGNF's ROE of -4.14%. Regarding short-term risk, AMCY is less volatile compared to EPGNF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs MBGNF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, MBGNF has a market cap of 172.6K. Regarding current trading prices, AMCY is priced at $3.00, while MBGNF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas MBGNF's P/E ratio is -1.00. In terms of profitability, AMCY's ROE is N/A, compared to MBGNF's ROE of +0.37%. Regarding short-term risk, AMCY and MBGNF have similar daily volatility (0.00).
AMCY vs NVTAQ Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, NVTAQ has a market cap of 85.9K. Regarding current trading prices, AMCY is priced at $3.00, while NVTAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas NVTAQ's P/E ratio is -0.00. In terms of profitability, AMCY's ROE is N/A, compared to NVTAQ's ROE of +0.00%. Regarding short-term risk, AMCY is less volatile compared to NVTAQ. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs ARYC Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, ARYC has a market cap of 79.3K. Regarding current trading prices, AMCY is priced at $3.00, while ARYC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas ARYC's P/E ratio is N/A. In terms of profitability, AMCY's ROE is N/A, compared to ARYC's ROE of +0.55%. Regarding short-term risk, AMCY is less volatile compared to ARYC. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs HCLC Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, HCLC has a market cap of 74K. Regarding current trading prices, AMCY is priced at $3.00, while HCLC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas HCLC's P/E ratio is N/A. In terms of profitability, AMCY's ROE is N/A, compared to HCLC's ROE of +0.11%. Regarding short-term risk, AMCY and HCLC have similar daily volatility (0.00).
AMCY vs MEDVF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, MEDVF has a market cap of 54K. Regarding current trading prices, AMCY is priced at $3.00, while MEDVF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas MEDVF's P/E ratio is -0.03. In terms of profitability, AMCY's ROE is N/A, compared to MEDVF's ROE of +0.57%. Regarding short-term risk, AMCY and MEDVF have similar daily volatility (0.00).
AMCY vs CHHL Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, CHHL has a market cap of 37.3K. Regarding current trading prices, AMCY is priced at $3.00, while CHHL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas CHHL's P/E ratio is N/A. In terms of profitability, AMCY's ROE is N/A, compared to CHHL's ROE of +0.00%. Regarding short-term risk, AMCY is less volatile compared to CHHL. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs IHTI Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, IHTI has a market cap of 32.5K. Regarding current trading prices, AMCY is priced at $3.00, while IHTI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas IHTI's P/E ratio is N/A. In terms of profitability, AMCY's ROE is N/A, compared to IHTI's ROE of +0.00%. Regarding short-term risk, AMCY is less volatile compared to IHTI. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs MEDD Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, MEDD has a market cap of 31.9K. Regarding current trading prices, AMCY is priced at $3.00, while MEDD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas MEDD's P/E ratio is -0.01. In terms of profitability, AMCY's ROE is N/A, compared to MEDD's ROE of +0.74%. Regarding short-term risk, AMCY and MEDD have similar daily volatility (0.00).
AMCY vs TOMDF Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, TOMDF has a market cap of 14.1K. Regarding current trading prices, AMCY is priced at $3.00, while TOMDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas TOMDF's P/E ratio is N/A. In terms of profitability, AMCY's ROE is N/A, compared to TOMDF's ROE of +0.84%. Regarding short-term risk, AMCY is less volatile compared to TOMDF. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs ABMC Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, ABMC has a market cap of 4.8K. Regarding current trading prices, AMCY is priced at $3.00, while ABMC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas ABMC's P/E ratio is 0.01. In terms of profitability, AMCY's ROE is N/A, compared to ABMC's ROE of +0.86%. Regarding short-term risk, AMCY and ABMC have similar daily volatility (0.00).
AMCY vs RGDXQ Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, RGDXQ has a market cap of 3.9K. Regarding current trading prices, AMCY is priced at $3.00, while RGDXQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas RGDXQ's P/E ratio is N/A. In terms of profitability, AMCY's ROE is N/A, compared to RGDXQ's ROE of -1.27%. Regarding short-term risk, AMCY is less volatile compared to RGDXQ. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs GWHP Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, GWHP has a market cap of 1.3K. Regarding current trading prices, AMCY is priced at $3.00, while GWHP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas GWHP's P/E ratio is -0.00. In terms of profitability, AMCY's ROE is N/A, compared to GWHP's ROE of +0.00%. Regarding short-term risk, AMCY is less volatile compared to GWHP. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs CGNH Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, CGNH has a market cap of 1.2K. Regarding current trading prices, AMCY is priced at $3.00, while CGNH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas CGNH's P/E ratio is N/A. In terms of profitability, AMCY's ROE is N/A, compared to CGNH's ROE of +1.41%. Regarding short-term risk, AMCY and CGNH have similar daily volatility (0.00).
AMCY vs CYPS Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, CYPS has a market cap of 811. Regarding current trading prices, AMCY is priced at $3.00, while CYPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas CYPS's P/E ratio is N/A. In terms of profitability, AMCY's ROE is N/A, compared to CYPS's ROE of N/A. Regarding short-term risk, AMCY is less volatile compared to CYPS. This indicates potentially lower risk in terms of short-term price fluctuations for AMCY.
AMCY vs ROSGQ Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, ROSGQ has a market cap of 593. Regarding current trading prices, AMCY is priced at $3.00, while ROSGQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas ROSGQ's P/E ratio is N/A. In terms of profitability, AMCY's ROE is N/A, compared to ROSGQ's ROE of -1.35%. Regarding short-term risk, AMCY and ROSGQ have similar daily volatility (0.00).
AMCY vs BIOCQ Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, BIOCQ has a market cap of 263. Regarding current trading prices, AMCY is priced at $3.00, while BIOCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas BIOCQ's P/E ratio is -0.00. In terms of profitability, AMCY's ROE is N/A, compared to BIOCQ's ROE of -1.38%. Regarding short-term risk, AMCY and BIOCQ have similar daily volatility (0.00).
AMCY vs HTGMQ Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, HTGMQ has a market cap of 221. Regarding current trading prices, AMCY is priced at $3.00, while HTGMQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas HTGMQ's P/E ratio is N/A. In terms of profitability, AMCY's ROE is N/A, compared to HTGMQ's ROE of -2.73%. Regarding short-term risk, AMCY and HTGMQ have similar daily volatility (0.00).
AMCY vs DMTKQ Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, DMTKQ has a market cap of 35. Regarding current trading prices, AMCY is priced at $3.00, while DMTKQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas DMTKQ's P/E ratio is N/A. In terms of profitability, AMCY's ROE is N/A, compared to DMTKQ's ROE of -0.80%. Regarding short-term risk, AMCY and DMTKQ have similar daily volatility (0.00).
AMCY vs OPGX Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, OPGX has a market cap of 17. Regarding current trading prices, AMCY is priced at $3.00, while OPGX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas OPGX's P/E ratio is N/A. In terms of profitability, AMCY's ROE is N/A, compared to OPGX's ROE of +0.46%. Regarding short-term risk, AMCY and OPGX have similar daily volatility (0.00).
AMCY vs MRPS Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, MRPS has a market cap of 0. Regarding current trading prices, AMCY is priced at $3.00, while MRPS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas MRPS's P/E ratio is N/A. In terms of profitability, AMCY's ROE is N/A, compared to MRPS's ROE of N/A. Regarding short-term risk, AMCY and MRPS have similar daily volatility (0.00).
AMCY vs BGNX Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, BGNX has a market cap of 0. Regarding current trading prices, AMCY is priced at $3.00, while BGNX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas BGNX's P/E ratio is N/A. In terms of profitability, AMCY's ROE is N/A, compared to BGNX's ROE of N/A. Regarding short-term risk, AMCY and BGNX have similar daily volatility (0.00).
AMCY vs AGHC Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, AGHC has a market cap of 0. Regarding current trading prices, AMCY is priced at $3.00, while AGHC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas AGHC's P/E ratio is N/A. In terms of profitability, AMCY's ROE is N/A, compared to AGHC's ROE of +2.90%. Regarding short-term risk, AMCY and AGHC have similar daily volatility (0.00).
AMCY vs EPGNY Comparison
AMCY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, AMCY stands at 171.3M. In comparison, EPGNY has a market cap of 0. Regarding current trading prices, AMCY is priced at $3.00, while EPGNY trades at $2.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
AMCY currently has a P/E ratio of N/A, whereas EPGNY's P/E ratio is -1.60. In terms of profitability, AMCY's ROE is N/A, compared to EPGNY's ROE of -0.19%. Regarding short-term risk, AMCY and EPGNY have similar daily volatility (0.00).